Study of Tirzepatide in Healthy Participants
ClinicalTrials.gov · NCT04311424 · Registry updated: 2023-03-24
- Condition / research focus
- Healthy
- Sponsor
- Eli Lilly and Company
- Countries with listed sites
- United Kingdom
- Registry dates and results
- Start: 2020-07-28. Completion: 2020-10-02 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- 14C Tirzepatide (drug) — also listed as: LY3298176
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Covance Clinical Research Ltd
Leeds, West Yorkshire, United Kingdom
Site recruitment: Not reported

